Skip to main content
CWBHF logo

CWBHF

Charlotte's Web Holdings, Inc.
$0.24 -0.03 (-10.33%) At close · Jul 15
Market Cap
$41.12M
Shares
160,605,889

Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.

Revenue
$49.9M +0.5%
FY2025 Revenue FY2020–FY2025
Net Income
-$29.74M +0.4%
FY2025 Net Income FY2020–FY2025
Gross Margin
43.49% +0.7pp
FY2025 Gross Margin FY2020–FY2025
Operating Margin
-40.62% +23.8pp
FY2025 Operating Margin FY2020–FY2025
Diluted EPS
-$0.19 0%
FY2025 Diluted EPS FY2020–FY2025
Operating Cash Flow
-$14.12M +33.6%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Line Item TTM FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
$48.79M $49.9M $49.67M $63.16M $74.14M $96.09M $95.23M
$28.12M $28.2M $28.41M $27.59M $54.73M $47.51M $42.94M
$20.67M $21.7M $21.26M $35.57M $19.41M $48.59M $52.29M
43.49% 42.81% 56.32% 26.18% 50.56% 54.91%
$1.81M $2.33M $2.96M $3.44M $5.5M $5.95M
$39.92M $41.97M $53.25M $75.63M $70.06M $97.64M $103.63M
$226K $218K $849K $1.23M $3.54M $2.01M
$6.32M $9.98M $15.16M $8.97M $11.03M $6.85M
-$19.24M -$20.27M -$31.99M -$40.61M -$52.49M -$147.06M -$51.34M
-40.62% -64.4% -64.31% -70.79% -153.04% -53.92%
-$13.95M -$22.01M -$25.45M -$43.52M -$136.03M -$44.5M
-$1.46M -$2.27M $1.57M -$2.69M $744K $51K $1.33M
$0 $10.7M $0
-$36.71M -$29.81M -$29.81M -$23.27M -$59.22M -$137.58M -$38.7M
-$71K -$68K $39K $529K $91K $143K -$8.01M
-$36.64M -$29.74M -$29.85M -$23.8M -$59.31M -$137.72M -$30.68M
-59.6% -60.09% -37.68% -80% -143.32% -32.22%
USD/shares -$0.19 -$0.19 -$0.16 -$0.40 -$0.98 -$0.25
USD/shares -$0.19 -$0.19 -$0.16 -$0.40 -$0.98 -$0.25
shares 158.79M 157.56M 152.94M 146.63M 140.77M 125.01M
shares 158.79M 157.56M 152.94M 146.63M 140.77M 125.01M
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Price & Valuation

Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.

Valuation

EV/Revenue
Drug Manufacturers - Specialty & Generic median 2.11×
EV/EBIT
Drug Manufacturers - Specialty & Generic median 34.24×
P/E (TTM)
Drug Manufacturers - Specialty & Generic median 20.87×

Revenue Breakdown

Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.

Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31
Reportable Segment $49,897,000 $49,667,000 $63,155,000

Segment Operating Income

Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.

By Segment (USD)

Component 2025-12-31 2024-12-31 2023-12-31
Reportable Segment -$20,268,000 -$31,987,000 -$40,612,000

Operating Margin by Segment (%)

Component 2025-12-31 2024-12-31 2023-12-31
Reportable Segment -40.6% -64.4% -64.3%
Key facts CIK 1750155 CUSIP 16106R109 13F (30d) 1 filings 1 filers Visit website Investor relations